Celularity Inc
For the period ended Dec 31, 2025. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 30, 2026
CELU$0.76-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $6,175 | $738 |
| Accounts receivable, net of allowance of $7,647 and $6,294 as of December 31, 2025 and 2024, respectively | 4,653 | 13,557 |
| Inventory | 571 | 5,409 |
| Prepaid expenses and other current assets | 920 | 857 |
| Total current assets | 12,319 | 20,561 |
| Property and equipment, net | 55,797 | 61,600 |
| Goodwill | 7,347 | 7,347 |
| Intangible assets, net | 7,756 | 9,248 |
| Right-of-use assets - operating | 10,720 | 10,830 |
| Restricted cash | 10,197 | 10,239 |
| Inventory, net of current portion | 2,946 | 12,587 |
| Other long-term assets | 247 | 270 |
| Total assets | $107,329 | $132,682 |
| Liabilities and Stockholders’ (Deficit) Equity | ||
| Current liabilities: | ||
| Accounts payable | $26,422 | $23,296 |
| Accrued expenses and other current liabilities | 32,574 | 20,492 |
| Short-term debt - unaffiliated | 9,563 | 2,485 |
| Short-term debt - related parties | 4,440 | 3,876 |
| Short-term license obligation | 2,113 | — |
| Deferred revenue | 5,255 | 3,531 |
| Preferred stock redemption liability | 300 | — |
| Derivative liability | 92 | — |
| Total current liabilities | 80,759 | 53,680 |
| Deferred revenue, net of current portion | 2,799 | 2,724 |
| Noncurrent debt - related parties | — | 35,927 |
| Noncurrent acquisition - related contingent consideration | 1,413 | 1,413 |
| Noncurrent lease liabilities - operating | 26,898 | 26,548 |
| Warrant liabilities | 1,545 | 3,264 |
| Long-term license obligation | 31,699 | — |
| Deferred income tax liabilities | 12 | 9 |
| Other liabilities | 266 | 280 |
| Total liabilities | 145,391 | 123,845 |
| Commitments and contingencies (Note 15) | — | — |
| Stockholders’ (deficit) equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 1,732,084 and 0 shares issued and outstanding as of December 31, 2025 and 2024, respectively | — | — |
| Common Stock, $0.0001 par value, 730,000,000 shares authorized; 28,837,787 and 22,546,671 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 3 | 2 |
| Additional paid-in capital | 953,418 | 908,523 |
| Accumulated other comprehensive loss | — | (5) |
| Accumulated deficit | (991,483) | (899,683) |
| Total stockholders’(deficit) equity | (38,062) | 8,837 |
| Total liabilities and stockholders’(deficit) equity | $107,329 | $132,682 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.